Sinovac Biotech Ltd
SVA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001084201
No open-market purchases or sales by Sinovac Biotech Ltd insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $224.9M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Sinovac Biotech Ltd as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- −17 vs. Q4 2021
- Shares held
- 6.39M
- −5.65M (−46.9%) vs. Q4 2021
- Total value
- $41.6M
- −$3.26M (−7.3%) vs. Q4 2021
- New holders
- 2
- 0 more added
- Sold out
- 19
- 2 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 28 | $224.9M |
| Q1 2026 | 28 | $40.4M |
| Q4 2025 | 28 | $225.3M |
| Q3 2025 | 27 | $225.0M |
| Q2 2025 | 28 | $375.4M |
| Q1 2025 | 3 | $336.0M |
| Q4 2024 | 4 | $336.0M |
| Q3 2024 | 9 | $418.4M |
| Q2 2024 | 26 | $79.6M |
| Q1 2024 | 26 | $80.7M |
| Q4 2023 | 8 | $342.0M |
| Q3 2023 | 30 | $43.2M |
| Q2 2023 | 29 | $5.58M |
| Q1 2023 | 4 | $957.4M |
| Q4 2022 | 9 | $380.2M |
| Q3 2022 | 30 | $44.0M |
| Q2 2022 | 31 | $44.0M |
| Q1 2022 | 11 | $41.6M |
| Q4 2021 | 29 | $44.9M |
| Q3 2021 | 29 | $44.9M |
| Q2 2021 | 28 | $44.9M |
| Q1 2021 | 29 | $44.8M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Sinovac Biotech Ltd; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 5,900,000 | $38.2M | 2.63% | 00.0% | Unchanged |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2.04M | 0.45% | 00.0% | Unchanged |
| Sofos Investments, Inc. | 144 | $796.0K | 0.07% | 00.0% | Unchanged |
| Yorktown Management & Research Co Inc | 74,893 | $485.0K | 0.41% | 00.0% | Unchanged |
| Eqis Capital Management, Inc. | 17,220 | $111.0K | 0.01% | −165−0.9% | Reduced |
| IFP Advisors, Inc | 18 | $8.00K | 0.00% | +18 | New |
| Navellier & Associates Inc | 15,828 | $0 | 0.00% | −6,350−28.6% | Reduced |
| California Public Employees Retirement System | 68,732 | $0 | 0.00% | 00.0% | Unchanged |
| Assetmark, Inc | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 424 | $0 | 0.00% | 00.0% | Unchanged |
| Sanders Morris Harris LLC | 2,000 | $0 | 0.00% | +2,000 | New |
| State Street Corp | 0 | $0 | 0.00% | −281,640−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −2,375,841−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −27,717−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −16,430−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −9,095−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −13,787−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −3,941−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −102−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −127−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −126−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −1,912−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −412−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −516−100.0% | Sold out |
| Spark Investment Management LLC | 0 | $0 | 0.00% | −29,100−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1,362−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −2,839,500−100.0% | Sold out |
| NEXT Financial Group, Inc | – | – | – | – | Not filed |